{"url_path":"/sec/goco/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 OTHER INFORMATION.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/1808220/0001628280-26-035953-index.html","accession_number":"0001628280-26-035953","cik":"0001808220","ticker":"GOCO","issuer_name":"GoHealth, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1808220/0001628280-26-035953-index.html","primary_entity_key":"0001808220","primary_entity_name":"GoHealth, Inc."},"word_count":62,"has_tables":true,"body_markdown":"ITEM 5. OTHER INFORMATION.\n\nDuring the quarter ended March 31, 2026, none of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted, modified, or terminated a Rule 10b5-1 trading plan or a non-Rule 10b5-1 trading arrangement for our securities (as defined in Item 408(c) of Regulation S-K).\n\nGoHealth, Inc.2026 Form 10-Q\n  35\n\nGoHealth, Inc.2026 Form 10-Q\n  36"}